The financial technology companies supported by Wal-Mart are valued at $2.5 billion. The traditional banking industry is under threat. Wal-Mart is injecting more funds into its newly-started financial start-ups, obtaining a valuation of $2.5 billion for this company, and indicating its ambition to further set foot in the financial services industry. According to informed sources, the world's largest retailer is jointly leading the financing of more than 300 million US dollars with investment company Ribbit Capital. This marks a new valuation for the company named One, in which Wal-Mart holds a majority stake. Wal-Mart has been providing products to many customers and employees in order to gain a greater foothold in the field of financial services. For the financial industry, the threat of Wal-Mart and other companies encroaching on its territory is getting closer and closer. Just last year, JPMorgan Chase CEO Jamie Dimon mentioned the competitive threat of Wal-Mart and other enterprises, pointing out that its hundreds of millions of customers and huge resources at its disposal were "extraordinary competitive advantages".Beijing Stock Exchange plans to carry out the fifth network-wide test of trading support platform optimization tomorrow. On December 13th, the office of Beijing Stock Exchange and the office of National Stock Transfer Company issued a notice to carry out the fifth network-wide test of trading support platform optimization on December 14th. The participating institutions are Beijing Stock Exchange, National Stock Transfer Company, China Clearing, Shenzhen Stock Connect, securities companies, fund companies and information providers.Market News: Lotte Chemical will suspend the Johor plant to reduce losses.
Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Bank of Communications International: For the first time, it covers the "buy" rating and target price of HK$ 5.86 given by the rich industrial trust. The Bank of Communications International published a report that the rich industrial trust has multiple investment advantages and stock price drivers, including stable profit prospects, low valuation, further interest rate cuts and potential inclusion in Shanghai-Shenzhen-Hong Kong Stock Connect, which are all beneficial to the valuation of REITs. For the first time, the bank covers the purchase of wealth and gives a "buy" rating with a target price of HK$ 5.86. Bank of Communications International believes that the rental income prospect of Zhifu Industrial Trust can remain basically stable. At the same time, the current share price corresponds to a dividend of 9.4% in 2025, and the gap between the dividend yield and the yield of 10-year US bonds is about 1.1 standard deviation lower than the long-term level. It is considered that the current valuation is still far below its long-term average level, and has reflected most of the worries of the retail market in Hong Kong. The report continued that although high interest rates will still have a negative impact on this year's earnings, it is expected that the dividend per unit of Zhifu will resume growth from next year under the condition of continuous interest rate reduction. It is expected that the dividend per unit will decrease by 10%, increase by 3.8% and increase by 4.1% from 2024 to 2026 to 36.34, 37.71 and 39.26 Hong Kong cents respectively.Market news: South Korean prosecutors approved the postponement of the execution of the ruling request of Cao Guo, the leader of the opposition motherland reform party.
Huang Hongfei, former CFO of McDonald's China, joined the company? Bawang Chaji: No response. Recently, it was reported in the market that Huang Hongfei, the former CFO of McDonald's China, recently left his post and joined Bawang Chaji after a short break. In response to this news, Bawang Chaji said that he would not respond. According to public information, Huang Hongfei joined McDonald's around 1995 and played an important role in the financial and strategic planning of McDonald's China. He was one of the key figures who witnessed the development of McDonald's China. (SSE)Alipay launched the commercial insurance code, and the first batch has been connected to Taikang and Zhongan medical insurance. On December 13th, Alipay launched the commercial insurance code. This means that after the patient has paid the medical insurance for hospitalization, if it needs to be supplemented, he can directly use the business insurance code to apply for prepayment of hospitalization expenses, and then initiate reimbursement claims to the insurance company. At present, users can open this service by searching for "business insurance code" on Alipay, and can apply for medical treatment quota according to the prompts. The first phase of the commercial insurance code has covered the mainstream millions of medical insurance under Taikang Online and Zhongan Online, and will cover more insurance institutions and insurance types in the future.Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.
Strategy guide 12-14
Strategy guide 12-14